Ophthalmology · Tampa, FL
NPI
1629199096
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
4178 N Armenia Ave
Tampa, FL, 33607
Phone (813) 999-3998
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
13,586 services
Medicare patients, 2024
478
Average age 77
Drug cost, 2024
$627K
446 prescriptions
Company payments, 2025
$2,419
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fayssal El-Jabali was code J2777 (injection, faricimab-svoa, 0.1 mg), 3,840 times for 22 patients. In total Fayssal El-Jabali billed 13,586 services in 33 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 3,840 | 22 | $27.27 | $105K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,950 | 123 | $640.99 | $1.2M |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 1,780 | 21 | $86.43 | $154K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 1,757 | 50 | $263.70 | $463K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,497 | 464 | $29.26 | $44K |
| 67028 Intravitreal Injection | Office | 1,232 | 189 | $93.22 | $115K |
| 99214 Office E&M - Established | Office | 857 | 400 | $95.30 | $82K |
| 99204 Office E&M - New | Office | 76 | 76 | $120.03 | $9,123 |
| 76512 Ultrasound - Nonspecific | Office | 69 | 45 | $36.56 | $2,522 |
| 67145 Eye | Office | 30 | 26 | $193.07 | $5,792 |
| 99205 Office E&M - New | Office | 17 | 17 | $181.79 | $3,090 |
| 99213 Office E&M - Established | Office | 14 | 14 | $69.24 | $969 |
By year: 2022 $1.4M for 6,028 services; 2023 $1.5M for 5,927 services; 2024 $2.3M for 13,586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fayssal El-Jabali prescribed most often to Medicare patients was Eylea (Aflibercept), with 168 prescriptions and refills. In total Fayssal El-Jabali wrote 446 Medicare prescriptions that cost $627K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 168 | 168 | 19 | $481K |
| Prednisolone Acetate Generic | 78 | 88 | 44 | $3,048 |
| Ofloxacin Generic | 27 | 28 | 26 | $300 |
| Atropine Sulfate Generic | 25 | 25 | 24 | $858 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 24 | 24 | 23 | $275 |
| Izervay Avacincaptad Pegol Sodium/Pf | 17 | 17 | Under 11 | $61K |
| Ketorolac Tromethamine Generic | 15 | 16 | Under 11 | $333 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 12 | 28 | Under 11 | $377 |
| Timolol Maleate Generic | 11 | 17 | Under 11 | $44.28 |
Brand drugs: 312 claims; generic drugs: 134 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fayssal El-Jabali $2,419 ($2,419 in general payments such as food, travel and fees) from 19 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $231 |
| Astellas Pharma US Inc 4503.T | 6 | $228 |
| Harrow Eye, LLC | 4 | $218 |
| Amgen Inc. AMGN | 4 | $207 |
| Genentech USA, Inc. ROG.SW | 3 | $201 |
| Mallinckrodt Hospital Products Inc. | 1 | $147 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $146 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $143 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $140 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.